Association of a functional 5-HT transporter gene polymorphism with anorexia nervosa and food intake SIR -Anorexia nervosa (AN) is regarded either as a primary eating disorder, or as a mood disorder leading to decrease in food intake. The serotonergic system is involved in both kinds of disorders. A functional polymorphism of the 5-HTT gene is located in the promoter region and consists of a 44-bp insertion or deletion. 1 The transcriptional activity of the short (S) variant is half that of the long (L) one, leading to a decrease in 5-HTT expression and finally in 5-HT uptake by 50%. 2 The aim of our study was to determine whether this polymorphism could influence eating behavior and food intake.
Three groups of population were studied: (1) AN patients (65 women, two men; age: 24.3 ± 6.5 years) hospitalized in the Nutrition Department of Bichat Hospital in Paris, fulfilling the DSM-IV criteria for AN, having severe malnutrition (BMI: 13.6 ± 1.9 kg m −2 ) and a restrictive form of the disease. (2) Normal weight controls (84 women, 64 men; age:
41.2 ± 4.1, BMI: 22.6 ± 2.1 kg m −2 ) drawn from the 
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Stanislas Study, composed of volunteers for a free health examination in the Nancy region. ; among these, 286 from Paris, 72 from Nancy). All subjects were French Caucasians. The spontaneous dietary intakes were assessed using the diet history method in Paris 4 and the 3-day record method in Nancy. 5 The polymorphism of the 5-HTT gene was analyzed by PCR amplification. 6 The SS genotype was significantly more frequent in AN patients than in other groups (Table 1) , frequency of the S allele being higher in the AN group (51.5%) and lower in the overweight subjects (39.8%) when compared to normal weight controls (44.6%) (P Ͻ 0.05). Even after exclusion of the AN group, the SS genotype was associated with lower energy intake ( Table 1 ). This was due to lower intakes of all the main nutrients, but only the difference in carbohydrates was statistically significant (Table 1 ). This can be related to the formerly described role of 5-HT in carbohydrate intake regulation, 7 even if it has now been shown that serotonin has suppressive effects on consumption of all rewarding substances.
In other studies of this polymorphism in anorexic patients, no significant association was found. [8] [9] [10] Our result might be a false positive because the AN sample is small. Nevertheless, in the more recent studies, 8, 9 an excess of S allele was found in AN although this was not statistically significant. The discrepancy with Hinney et al 10 could be due to a different selection of patients. In Hinney et al, 10 patients were younger (mean age: 16 years) than patients in our study (24 years). Mean course of the disease in our patients could thus be longer. In the younger patients from our sample (Ͻ 20 years, n = 16), the S frequency was 41%, similar to the non AN groups, whereas in the older (Ն 20 years, n = 51), the S frequency was 55%, which indicates that the S allele could predispose to a protracted course of AN.
There is a great consistency between our results and the in vitro effects of the S allele. 2 The effects of the S allele are quite similar to that of serotonergic anorectic drugs inhibiting reuptake of the 5-HT. However, the effects observed here may be secondary to behavioral or psychological traits possibly associated with this polymorphism. 1 identify four proteins, based on partial protein sequence, isoelectric point, and molecular weight, which appear to be expressed at different amounts in schizophrenia brains vs normal brains, specifically in the hippocampus. The authors' key conclusion regarding localization of the proteins which they identified is that three of the four localize to chromosome 6q, a result which they calculate to be significant at the P = 0.002 level.
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We have disagreements with Edgar et al 1 in three main areas:
(1) The number of their isolated proteins which map to chromosome 6q: Edgar et al 1 identifies one of these three proteins as diazepam binding inhibitor (DBI) and note it to map to 6q12-q21 on an inconsistent basis via OMIM. This is indeed listed as one of the two loci for DBI (OMIM 125950), the other one being 2q12-q21. However, in the first paragraph of the text of the OMIM entry for DBI, this inconsistency is explained. The functional gene for DBI indeed resides on 2q12-q21, but a pseudogene named DBIL2 resides on 6q12-q21 via a careful study by Gersuk et al. 2 The authors 2 cite several lines of evidence indicating that DBIL2 is a pseudogene: (1) it lacks introns predicted from other species; (2) a one base pair deletion in the potential coding region which is in an important functional domain results in a framshift and a resultant premature stop codon; (3) its homology to the functional DBI is restricted to the transcribed region with quite sharp boundaries suggesting DBIL2 arose by means of genomic integration of a processed message since very little of the expected 5Ј or 3ЈUTRs (untranslated regions) predicted by homology comparisons to other species (and the human functional DBI) are present; (4) it is flanked by direct repeats which is a characteristic of processed pseudogenes; 3 and (5) it has no detectable RNA transcript. 2 Finally, the authors explain why a previous study 4 placed DBI on 6q12-q21: their antisense PCR primer would have been interrupted by an intron in the functional gene, but not in the pseudogene. 2 Edgar et al 1 refer to their earlier paper 5 to describe the identification process for a spot on their twodimensional electrophoresis (2DE) gels which appeared decreased in concentration in schizophrenic hippocampi compared to normal controls. After recovery from a preparative 2DE gel, the protein was subjected to trypsin digestion and one of the peptides was determined by N-terminal sequencing to have the sequence of TKPSDEEM. 5 It was not explained why trypsin, which cleaves after (on the carboxyl side) of lysine (K) and arginine (R) residues no matter the size, failed to cleave after the lysine in this fragment, although it is likely that this is due to a proline (P) residue on the carboxyl side of this lysine. 6 Still, this sequence of amino acids is indeed found to be identical to residues 18 through 25 of the functional DBI (GenBank M15887), and this peptide is immediately preceded by a lysine residue in the intact protein.
However, even if DBIP1 were expressed, the residues at this site would be TKPGDDEM as predicted from the nucleotide sequence (GenBank L27274), and this is different from what was found at two of the eight residues by Edgar et al. 5 Hence, the spot identified by Edgar et al
